Citigroup’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-117,425
| Closed | -$3.85M | – | 6685 |
|
|
2022
Q2 | $3.85M | Buy |
117,425
+84,628
| +258% | +$2.67M | ﹤0.01% | 1682 |
|
|
2022
Q1 | $862K | Buy |
32,797
+2,009
| +7% | +$49K | ﹤0.01% | 3105 |
|
|
2021
Q4 | $730K | Buy |
30,788
+8,277
| +37% | +$204K | ﹤0.01% | 3546 |
|
|
2021
Q3 | $564K | Sell |
22,511
-7,409
| -25% | -$189K | ﹤0.01% | 3526 |
|
|
2021
Q2 | $777K | Buy |
29,920
+15,293
| +105% | +$416K | ﹤0.01% | 3418 |
|
|
2021
Q1 | $374K | Sell |
14,627
-4,648
| -24% | -$119K | ﹤0.01% | 3658 |
|
|
2020
Q4 | $386K | Buy |
19,275
+237
| +1% | +$4.64K | ﹤0.01% | 4433 |
|
|
2020
Q3 | $326K | Sell |
19,038
-30,850
| -62% | -$583K | ﹤0.01% | 4220 |
|
|
2020
Q2 | $1.09M | Buy |
49,888
+28,452
| +133% | +$651K | ﹤0.01% | 3473 |
|
|
2020
Q1 | $496K | Sell |
21,436
-24,532
| -53% | -$713K | ﹤0.01% | 3879 |
|
|
2019
Q4 | $1.52M | Buy |
45,968
+8,191
| +22% | +$263K | ﹤0.01% | 3299 |
|
|
2019
Q3 | $1.2M | Buy |
37,777
+10,475
| +38% | +$305K | ﹤0.01% | 3430 |
|
|
2019
Q2 | $702K | Buy |
27,302
+5,231
| +24% | +$133K | ﹤0.01% | 4066 |
|
|
2019
Q1 | $560K | Buy |
22,071
+10,748
| +95% | +$321K | ﹤0.01% | 4062 |
|
|
2018
Q4 | $385K | Buy |
11,323
+789
| +7% | +$25.7K | ﹤0.01% | 4404 |
|
|
2018
Q3 | $375K | Buy |
10,534
+2,860
| +37% | +$101K | ﹤0.01% | 4618 |
|
|
2018
Q2 | $265K | Sell |
7,674
-2,341
| -23% | -$82.1K | ﹤0.01% | 4774 |
|
|
2018
Q1 | $337K | Buy |
10,015
+778
| +8% | +$24.6K | ﹤0.01% | 4409 |
|
|
2017
Q4 | $353K | Sell |
9,237
-11,318
| -55% | -$452K | ﹤0.01% | 4477 |
|
|
2017
Q3 | $771K | Sell |
20,555
-7,109
| -26% | -$251K | ﹤0.01% | 3648 |
|
|
2017
Q2 | $1.03M | Sell |
27,664
-4,830
| -15% | -$174K | ﹤0.01% | 3279 |
|
|
2017
Q1 | $1.28M | Sell |
32,494
-26,610
| -45% | -$998K | ﹤0.01% | 2967 |
|
|
2016
Q4 | $2.06M | Buy |
59,104
+37,200
| +170% | +$1.46M | ﹤0.01% | 2910 |
|
|
2016
Q3 | $861K | Buy |
21,904
+7,095
| +48% | +$283K | ﹤0.01% | 3383 |
|
|
2016
Q2 | $559K | Sell |
14,809
-8,831
| -37% | -$296K | ﹤0.01% | 3557 |
|
|
2016
Q1 | $908K | Buy |
23,640
+23,283
| +6,522% | +$867K | ﹤0.01% | 3446 |
|
|
2015
Q4 | $17K | Buy |
357
+310
| +660% | +$14.3K | ﹤0.01% | 6578 |
|
|
2015
Q3 | $2K | Sell |
47
-464
| -91% | -$19.7K | ﹤0.01% | 7074 |
|
|
2015
Q2 | $22K | Buy |
511
+71
| +16% | +$2.83K | ﹤0.01% | 6058 |
|
|
2015
Q1 | $17K | Buy |
440
+423
| +2,488% | +$15.6K | ﹤0.01% | 6186 |
|
|
2014
Q4 | $1K | Sell |
17
-1,429
| -99% | -$48K | ﹤0.01% | 7014 |
|
|
2014
Q3 | $43K | Buy |
1,446
+523
| +57% | +$14.4K | ﹤0.01% | 5411 |
|
|
2014
Q2 | $24K | Buy |
923
+25
| +3% | +$618 | ﹤0.01% | 5711 |
|
|
2014
Q1 | $23K | Sell |
898
-9,496
| -91% | -$239K | ﹤0.01% | 5951 |
|
|
2013
Q4 | $234K | Buy |
10,394
+7,912
| +319% | +$153K | ﹤0.01% | 4517 |
|
|
2013
Q3 | $35K | Sell |
2,482
-3,003
| -55% | -$40.2K | ﹤0.01% | 5558 |
|
|
2013
Q2 | $75K | Buy |
+5,485
| New | +$74.7K | ﹤0.01% | 5088 |
|
Other funds holding NTUS
Citigroup's NTUS Position: Q3 2022 in Review
Citigroup sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 117,425 shares — an estimated $3.85M sold.
Citigroup first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $3.85M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Citigroup reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Citigroup sold 117,425 Natus Medical Inc shares in Q3 2022, an estimated $3.85M.
- Citigroup first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Citigroup's Natus Medical Inc position peaked at $3.85M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.